Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Medicine

Topics

Medicine

Cancer Oncology

Internal Medicine

Pulmonary And Respiratory Medicine

Molecular Biology

Show all topics

DOI

10.1038/nm.3667

Other Formats

PDF